Understanding the Genetic
Architecture of Parkinson's Disease

The Global Parkinson’s Genetics Program (GP2) is an ambitious five-year program to genotype >150,000 volunteers around the world to further understand the genetic architecture of Parkinson’s disease (PD). There is still much to learn about genetic risk factors and the path to further understanding requires working collaboratively and openly sharing data, processes, and results.

Access Training

Training is central to the GP2 effort. Learn more about our courses.

Submit a Cohort

Collaborate with us and submit a cohort to GP2. Fill out our form to get started.

GP2 Updates

Check out the latest news about GP2.

  • First-of-its-Kind DNA Biobank Opens in Peru

    ASAP, through GP2 and in partnership with LARGE-PD and the MJFF, celebrated a shared milestone with the inauguration of the DNA Biobank at the Instituto Nacion…

  • Researching Parkinson’s disease genetics on a global scale

    This Movement Disorders article explores GP2's ambitions to facilitate the rapid expansion of our understanding of the genetic architecture of PD, both in term…

  • Black and African American Connections to PD

    GP2 launched BLAAC PD: Black and African American Connections to Parkinson’s Disease, as part of our commitment to increase representation in research and care…

Latest Blog Posts

Read the latest blogs from GP2’s scientists and collaborators.

  • Overcoming Challenges to Black and African American Representation in Parkinson’s Research

    By CARE | GP2 Values, Underrepresented Populations |

    Members of CARE, a partner in the BLAAC PD study, address the importance of this study, the challenges of building a cohort, and the strategies in overcoming t…

  • Understanding Genetic Implications of the Black and African American Connections to Parkinson’s Disease Study (BLAAC PD)

    By Sara Bandres-Ciga, Justin C. Solle, Alyssa Reimer, and Bernadette Siddiqi | GP2 Values, Underrepresented Populations |

    Over the last two decades, we have witnessed a revolution in the research area of complex genetic diseases, including Parkinson’s disease. Great advances have …

  • Building Clinical and Genetic Data for GP2 in the Cohort Integration Working Group

    By Huw Morris | Complex disease genetics |

    Huw Morris leads the Cohort Integration working group (CIWG). In this blog post, Huw provides an outline of the research on Parkinson’s disease over the last 2…

Working Groups

Find out about GP2’s working groups and their recently accomplished milestones.